About TGFBI Corneal Dystrophy. TGFBI corneal dystrophy is a group of genetic eye disorders caused by mutations in the TGFBI gene, resulting in abnormal protein buildup in the stromal layer of cornea.

Future Market Insights (FMI) has unveiled a compelling new report forecasting significant expansion in the global fuchs endothelial corneal dystrophy market.The report highlights a surge in market ...

The fuchs endothelial corneal dystrophy market is expected to experience significant growth in the coming years, propelled by the development of innovative non-surgical therapies, an increasing ...

CARLSBAD, Calif., April 21, 2025 (GLOBE NEWSWIRE) -- Design Therapeutics, Inc. (Nasdaq: DSGN), a clinical-stage biotechnology company developing treatments for serious degenerative genetic ...

TORONTO--(BUSINESS WIRE)--Satellos Bioscience Inc. (TSX: MSCL, OTCQB: MSCLF) (“Satellos” or the “Company”), a biotech company developing new small molecule therapeutic approaches to improve the ...

Fuchs’ corneal dystrophy is a genetic eye disease. In the early stages, it causes bumps called guttae to form on cells in your cornea. In the late stages, it can make your cornea swell.

The most common is Fuchs’ corneal dystrophy, which usually starts when you’re in your 40s or 50s. It may take several more years, even decades before you notice vision problems.

In 1910, Professor Ernst Fuchs, an Austrian ophthalmologist, published an article describing 13 patients with Fuchs’ dystrophy, a condition in the cornea that subsequently bears his name. The ...

The market for Fuchs endothelial corneal dystrophy is expected to boost in the coming years. This growth can be attributed to the introduction of upcoming therapies and the rising prevalence of ...

The corneal endothelium is a thin layer of cells that forms the inner lining of the cornea. A human eye has approximately 7500 endothelial cells per square millimeter .